Source:http://linkedlifedata.com/resource/pubmed/id/20042470
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-4-1
|
pubmed:abstractText |
Sexual transmission is the primary route of HIV-1 infection, and DC subsets are thought to be involved in viral dissemination to T cells. In the genital mucosa, two main subsets of DCs are present: epithelial LCs capture and degrade HIV-1 through C-type lectin Langerin, whereas subepithelial DCs express DC-SIGN, which facilitates HIV-1 transmission to T cells. As there is currently no HIV-1 vaccine available, microbicides provide an alternative strategy to limit HIV-1 spread. However, research into the function of LCs is hampered by the low availability and donor differences. Here, we set out to investigate whether LCs derived from the Mutz-3 cell line (Mu-LCs) provide a valuable tool to investigate the role of LCs in HIV-1 transmission and identify suitable potential microbicides. We demonstrate that Mu-LCs phenotypically resemble human primary LCs; Mu-LCs do not transmit HIV-1 efficiently, and inhibition of Langerin enhances HIV-1 transmission to T cells. We show that carbohydrate structures blocking DC-SIGN but not Langerin are potential microbicides, as they prevent HIV-1 transmission by DCs but do not affect the antiviral function of LCs. Therefore, Mu-LCs are a suitable model to investigate the role of LCs in HIV-1 transmission and to screen potential microbicides.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/CD207 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Lectins, C-Type,
http://linkedlifedata.com/resource/pubmed/chemical/Mannose-Binding Lectins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1938-3673
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
637-43
|
pubmed:meshHeading |
pubmed-meshheading:20042470-Anti-HIV Agents,
pubmed-meshheading:20042470-Antigens, CD,
pubmed-meshheading:20042470-Drug Evaluation, Preclinical,
pubmed-meshheading:20042470-HIV Infections,
pubmed-meshheading:20042470-HIV-1,
pubmed-meshheading:20042470-Humans,
pubmed-meshheading:20042470-Jurkat Cells,
pubmed-meshheading:20042470-Langerhans Cells,
pubmed-meshheading:20042470-Lectins, C-Type,
pubmed-meshheading:20042470-Mannose-Binding Lectins,
pubmed-meshheading:20042470-Models, Biological,
pubmed-meshheading:20042470-T-Lymphocytes
|
pubmed:year |
2010
|
pubmed:articleTitle |
Mutz-3-derived Langerhans cells are a model to study HIV-1 transmission and potential inhibitors.
|
pubmed:affiliation |
Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands 1105AZ.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|